Download PDF
Thromb Haemost 1993; 69(04): 381-386
DOI: 10.1055/s-0038-1651616
Original Article
Fibrinolysis
Schattauer GmbH Stuttgart

Retinoic Acid Enhances Fibrinolytic Activity In-Vivo by Enhancing Tissue Type Plasminogen Activator (t-PA) Activity and Inhibits Venous Thrombosis

J J J van Giezen
1   Solvay Duphar B. V., Dept. of Vascular Pharmacology, Weesp, The Netherlands
,
G d I A Boon
1   Solvay Duphar B. V., Dept. of Vascular Pharmacology, Weesp, The Netherlands
,
J W C M Jansen
1   Solvay Duphar B. V., Dept. of Vascular Pharmacology, Weesp, The Netherlands
,
B N Bouma
2   University Hospital Utrecht, Dept. of Haematology, Utrecht, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 18 August 1992

Accepted after revision 10 December 1992

Publication Date:
05 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

We studied the profibrinolytic effect and the anti-thrombotic potential of retinoic acid in-vivo. Male Wistar rats were treated with retinoic acid either acutely or twice daily for a period of 5 consecutive days in a dose range of 0.01 to 3.0 mg/kg. Fibrinolytic activity was measured ex-vivo using the diluted blood clot lysis test and net t-PA activity in tissue extracts was measured in a spectrophotometric rate assay. Clot lysis was dose dependently increased by retinoic acid up to about 170% (relative to vehicle treated rats) at a dose of 3 mg/kg. No tachyphylaxis could be detected. Ex-vivo measured fibrinolytic activity after single administration of 1 mg/kg of retinoic acid peaked at 3 h after ingestion. Even after 18 h a significantly higher clot lysis rate was measured. Lysis of blood clots from vehicle and retinoic acid treated rats could be completely blocked by addition of tranexamic acid or antibodies against rat t-PA before clot formation. t-PA activity in plasma was slightly increased after retinoic acid treatment; no effects were measured on plasma PAI-1, u-PA, plasminogen, and α2-antiplasmin levels. t-PA activity in lung and kidney was marginally enhanced by retinoic acid but in heart and aortic tissue extracts t-PA activity was increased by about 50%. We confirmed this potential anti-thrombotic property in an in-vivo venous thrombosis model. A reduced clot size was observed after retinoic acid administration (35% reduction at a dose of 1 mg/kg). We could not detect any effect on ex-vivo measured platelet aggregation, bleeding time, prothrombin time, thrombin time, partial thromboplastin time or plasma fibrinogen level, indicating that there were no effects on platelet aggregation or blood coagulation. We conclude that retinoic acid enhanced fibrinolytic activity in-vivo by selectively enhancing t-PA activity and that retinoic acid is a potential anti-thrombotic agent in-vivo.

 

  • References

  • 1 Gelehrter TD, Sznycer-Laszuk R, Zeheb R, Cwikel BJ. Dexa-methasone inhibition of tissue-type plasminogen activator (t-PA) activity: paradoxical induction of both t-PA antigen and plasminogen activator inhibitor. Mol Endocrinol 1987; 1: 97-101
    CrossrefPubMedGoogle Scholar
  • 2 van Giezen JJJ, Jansen JWCM. Inhibition of fibrinolytic activity in vivo by dexamethasone is counterballanced by an inhibition of platelet aggregation. Thromb Haemostas 1992; 68: 69-73
    PubMedGoogle Scholar
  • 3 Bulens F, Nelles L, Van den Panhuyzen N, Collen D. Stimulation by retinoids of tissue-type plasminogen activator secretion in cultured human endothelial cells: relations of structure to effect. J Cardiov Phar 1992; 19: 508-514
    PubMedGoogle Scholar
  • 4 Kooistra T, Opdenberg JP, Toet K, Hendriks HFJ, Van den Hoogen RM, Emeis JJ. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo. Thromb Haemostas 1991; 65: 565-572
    PubMedGoogle Scholar
  • 5 Thompson EA, Nelles L, Collen D. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells. Eur J Biochem 1991; 201: 627-632
    CrossrefPubMedGoogle Scholar
  • 6 Kojima S, Soga W, Hagiwara H, Shimonaka M, Saito Y, Inada Y. Visible fibrinolysis by endothelial cells. Effect of vitamins and sterols. Biosci Rep 1986; 6: 1029-1034
    CrossrefPubMedGoogle Scholar
  • 7 Inada Y, Hagiwara H, Kojima S, Shimonaka M, Saito Y. Synergism of vitamins A and C on fibrinolysis. Biochem Biophys Res Commun 1985; 130: 182-187
    CrossrefPubMedGoogle Scholar
  • 8 Lotan R, Lotan D, Kadouri A. Comparison of retinoic acid effects on anchorage-dependent growth, anchorage-independent growth and fibrinolytic activity of neoplastic cells. Exp Cell Res 1982; 141: 79-86
    CrossrefPubMedGoogle Scholar
  • 9 Tautt J, Chlopkiewics B, Koziorowska J, Mazur N. Effects of retinoic acid on fibrinolytic activity in different cell systems. Eur J Cell Biol 1986; 15 (Suppl. 00) 47
    PubMedGoogle Scholar
  • 10 Ghezzo F, Pegoraro L. Effects of retinoic-acid on the fibrinolytic acivity of HL 60 human promyelocytic leukemia cells. Experimentia 1981; 37: 425-426
    CrossrefPubMedGoogle Scholar
  • 11 Alving BM, Krishnamurti C, Liu Y-P, Lucas DL, Wright DG. Stimulated production of urokinase and plasminogen activator inhibitor-2 by the human promyelocytic leukemia cell line HL-60. Thromb Res 1988; 51: 175-186
    CrossrefPubMedGoogle Scholar
  • 12 Meats JE, Elford PR, Bunning RAD, Russel RGG. Retinoids and synovial factor(s) stimulate the production of plasminogen activator by cultured human chondrocytes.A possible role for plasminogen activator in the resorption of cartilage in vitro. Biochim Biophys Acta 1985; 838: 161-170
    CrossrefPubMedGoogle Scholar
  • 13 Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Näär AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG. RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 1991; 67: 1251-1266
    CrossrefPubMedGoogle Scholar
  • 14 Haq RU, Pfahl M, Chyntil F. Retinoic acid affects the expression of nuclear retinoic acid receptors in tissues of retinol-deficient rats. Proc Natl Acad Sci 1991; 88: 8272-8276
    CrossrefPubMedGoogle Scholar
  • 15 Astrom A, Tavakkol A, Petterson U, Cromie M, Elder JT, Voorhees JJ. Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). Retinoic acid induced expression of CRABP-II but not CRABP-I in adult human skin in vivo and in skin fibroblasts in vitro. J Biol Chem 1991; 266: 17662-17667
    PubMedGoogle Scholar
  • 16 Wolf G. The intracellular vitamin A-binding proteins: an overview of their functions. Nutr Rev 1991; 49: 1-12
    PubMedGoogle Scholar
  • 17 Kraft JC, Bui T, Juchau MR. Elevated levels of all-trans-retinoic acid in cultured rat embryos 1.5 hr after intraamniotic microinjections with 13-cis-retinoic acid or retinol and correlations with dysmorphogenesis. Biochem Pharmacol 1991; 42: R21-R24
    CrossrefPubMedGoogle Scholar
  • 18 Maden M, Summerbell D, Maigan J, Darmon M, Shroot B. The respecification of limb pattern by new synthetic retinoids and their interaction with cellular retinoic acid-binding protein. Differentiation 1991; 47: 49-55
    CrossrefPubMedGoogle Scholar
  • 19 Fearnley GR, Balmforth G, Fearnley E. Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis. Clin Sci 1957; 16: 645-650
    PubMedGoogle Scholar
  • 20 Padro T, van den Hoogen CM, Emeis JJ. Distribution of tissue-type plasminogen activator (activity and antigen) in rat tissues. Blood Coagulation Fibrinolysis 1990; 1: 601-608
    PubMedGoogle Scholar
  • 21 Verheijen JH, Mullaart E, Chang GTC, Kluft C, Wijngaards G. A simple sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemostas 1982; 48: 266-269
    PubMedGoogle Scholar
  • 22 Blombäck B, Blombäck M, Hessel B, Iwanaga S. Structure of n-terminal fragments of fibrinogen and specificity of thrombin. Nature 1967; 215: 1445-1448
    CrossrefPubMedGoogle Scholar
  • 23 Vasalli JP, Belin D. Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 1987; 214: 187-191
    CrossrefPubMedGoogle Scholar
  • 24 Kluft C, Wijngaards G, Jie AFH, Groeneveld E. Appropriate milieu for the assay of alpha-2-antiplasmin activity with chromogenic substrates. Haemostasis 1985; 15: 198-203
    PubMedGoogle Scholar
  • 25 Kumada T, Ishirara M, Ogawa H, Abiko Y. Experimental model of venous thrombosis in rats and effects of some agents. Thromb Res 1980; 18: 189-203
    CrossrefPubMedGoogle Scholar
  • 26 Lowry OH, Rosebourgh NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275
    PubMedGoogle Scholar
  • 27 Born GVR. Aggregation of blood platelets by adenosinediphosphate and its reversal. Nature 1962; 194: 927-929
    PubMedGoogle Scholar
  • 28 Horie S, Kizaki K, Ishii H, Kazama M. Retinoic acid stimulates expression of thrombomodulin, a cell surface anticoagulant glycoprotein, on human endothelial cells. Biochem J 1992; 281: 149-154
    CrossrefPubMedGoogle Scholar
  • 29 Krishnamurti C, Young GD, Barr CF, Colleton CA, Alving BM. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits. J Lab Clin Med 1991; 118: 523-530
    PubMedGoogle Scholar
  • 30 McCarthy DJ, Lindamood C, Gundberg CM, Hill DL. Retinoid-induced hemorrhaging and bone toxicity in rats fed diets deficient in vitamin K. Toxicol Appl Pharmacol 1989; 97: 300-310
    CrossrefPubMedGoogle Scholar
  • 31 Quax PHA, van den Hoogen CM, Verheijen JH, Padro T, Zeheb R, Gelehrter TD, van Berkel TJC, Kuiper J, Emeis JJ. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissue in vivo. J Biol Chem 1990; 265: 15560-15563
    PubMedGoogle Scholar
  • 32 Bounameaux H, Reber G, Bounameaux Y. Acute effect of retinoids on fibrinolysis before and after venous occlusion in healthy humans. Thromb Res 1988; 50: 175-179
    CrossrefPubMedGoogle Scholar